Form 4: MariMed Inc. Executive Reports Stock Transactions

MariMed Inc. Chief Operating Officer Timothy Shaw reported transactions involving common stock and restricted stock units, including acquisitions and withholdings for tax purposes.

Summary

• Timothy Shaw, Chief Operating Officer of MariMed Inc., filed a Form 4 detailing transactions related to the company's common stock.
• On May 29, 2026, Shaw acquired 40,625 shares of common stock with a transaction code 'M', valued at $0.
• Additionally, 14,077 shares were withheld to cover tax obligations upon the vesting of Restricted Stock Units (RSUs), with a value of $0.0805 per share.
• Following these transactions, Shaw beneficially owns 9,384,248 shares directly.
• The filing also notes 2,000,000 shares held indirectly through the Shaw Family Trust, for which Shaw disclaims beneficial ownership.
• RSUs were granted on November 29, 2024, with remaining vesting dates on November 29, 2026, May 29, 2027, and November 29, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents routine insider stock transactions and RSU vesting, with no significant positive or negative financial implications immediately apparent from the transaction details alone.

Positives

• Acquisition of 40,625 shares of common stock by the Chief Operating Officer.
• Vesting of Restricted Stock Units, indicating progress in executive compensation plans.
• The COO continues to hold a significant number of shares, suggesting continued commitment to the company.

Negatives

• 14,077 shares were withheld to cover tax obligations, representing a reduction in the net shares received by the executive.
• The disclaimer of beneficial ownership for shares held in the Shaw Family Trust may indicate a complex ownership structure.

Risks

• The disclaimer of beneficial ownership for shares held in the Shaw Family Trust could lead to scrutiny regarding ultimate control and beneficial ownership.
• Tax withholding obligations on RSUs, while standard, represent a cost to the executive.

Future Outlook

The remaining Restricted Stock Units are scheduled to vest in installments through November 2027, indicating a continued incentive structure for the Chief Operating Officer over the next few years.

Management Comments

• The Reporting Person disclaims beneficial ownership of securities held in the Shaw Family Trust, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors, providing transparency into insider stock transactions. This filing from MariMed Inc.'s COO is typical for companies with equity-based compensation plans.

Related Party Transactions

• The Shaw Family Trust holds 2,000,000 shares, with the Reporting Person's spouse as trustee. The Reporting Person disclaims beneficial ownership of these shares.

Stakeholder Impact

• Shareholders gain transparency into executive compensation and stock ownership.
• Employees may see RSU vesting as a positive indicator of executive commitment and company performance.

Next Steps

• Continued vesting of Restricted Stock Units through November 2027.
• Potential future transactions by Timothy Shaw as disclosed in subsequent SEC filings.

Key Dates

Keywords

MariMed Inc., MRMD, Form 4, Timothy Shaw, Chief Operating Officer, Stock Transaction, Common Stock, Restricted Stock Units, RSU Vesting, Beneficial Ownership, SEC Filing